메뉴 건너뛰기




Volumn 16, Issue 1, 2002, Pages 69-77

A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis

Author keywords

[No Author keywords available]

Indexed keywords

BALSALAZIDE; SALAZOSULFAPYRIDINE;

EID: 0036164249     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01151.x     Document Type: Article
Times cited : (62)

References (28)
  • 8
    • 0018961746 scopus 로고
    • Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: A study to determine the active therapeutic moiety of sulphasalazine
    • (1980) Gut , vol.21 , pp. 632-635
    • Van Hees, P.A.M.1    Bakker, J.H.2    Van Tongeren, J.H.M.3
  • 14
    • 0000953592 scopus 로고    scopus 로고
    • A multi-center, double-blind dose-response trial of Colazide (balsalazide disodium) and Asacol (mesalamine) for mild-moderately active ulcerative colitis
    • Abstract
    • (1997) Gastroenterology , vol.112
    • Levine, D.S.1    Pruitt, R.2    Riff, D.3
  • 27
    • 0024587677 scopus 로고
    • Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis a randomised trial
    • (1989) Br Med J , vol.298 , pp. 82-86
    • Rachmilewitz, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.